|
MechanismAMPA receptor antagonists [+3] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date24 Dec 1996 |
100 Clinical Results associated with Intro Bio Pharma Inc.
0 Patents (Medical) associated with Intro Bio Pharma Inc.
100 Deals associated with Intro Bio Pharma Inc.
100 Translational Medicine associated with Intro Bio Pharma Inc.